This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Trials Europe
29 - 30 November, 2023
CCIB, Barcelona
Menu
keyboard_arrow_right

DAY ONE: PLENARY - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

DAY ONE: PLENARY - CET/CEST (Cent Europe Summer, GMT+2)

search
13:00 - 13:5050 mins
PLENARY
Registration
    13:50 - 13:555 mins
    PLENARY
    Welcome to Day One
    • Louisa Maitland - Conference Director, Informa, UK
    13:55 - 14:005 mins
    PLENARY
    Chairperson Opening Comments
    • Bert Hartog - Senior Director, Focus Area Lead, Janssen Clinical Innovation, Janssen R&D, The Netherlands
    14:00 - 14:4040 mins
    PLENARY
    Inspirational Speaker: How the Health(care) Scene is Reshaping from Outside-in
    • Lucien Engelen - Strategist (Digital) Health Transformation for Deloitte, Vodafone, Laurentius Medical Center, The Netherlands
    14:40 - 15:1030 mins
    PLENARY
    CASE STUDY: Practical Experiences in Future Proofing Clinical Trials using Decentralized Approaches
    • Wendi Lau - Senior Director, Clinical Development Operations, Abbvie, USA
    15:10 - 15:4030 mins
    PLENARY
    Digital Measure Development, the Maturity of the Field, and What That Means for Clinical Trials
    • Jennifer Goldsack - CEO, Digital Medicine Society (DiMe), USA
    15:40 - 16:1030 mins
    PLENARY
    Assuring Quality in Clinical Trials During and Post-Pandemic
    • Janis Little - Vice President, Global R&D Quality, Moderna, USA
    16:50 - 17:5060 mins
    PLENARY
    PANEL: Looking into the Clinical Future: What Will Stay Post Pandemic?
    • Bill Hanlon - President CDCS, Clinical Therapeutic & Regulatory Science & Chief Scientific Officer, Labcorp, USA
    • Bert Hartog - Senior Director, Focus Area Lead, Janssen Clinical Innovation, Janssen R&D, The Netherlands
    • Kenneth Getz - Director & Research Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, USA
    • Richard Stephens - Co-Editor-in-Chief, Journal of Research Involvement and Engagement, UK
    • Janis Little - Vice President, Global R&D Quality, Moderna, USA
    • Lada Leyens - Senior Director - Regulatory Clinical Trial Innovation and Digital Health, Roche, Switzerland
    • Chris Fikry - President and Chief Executive Officer, Clario, USA
    17:50 - 18:2030 mins
    PLENARY
    Anticipating Real Change in Clinical Trial Design and Execution 5 Years from Now?
    • Kenneth Getz - Director & Research Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, USA
    NextDAY TWO
    Filter
    Streams
    Clear
    Formats
    Choose Day